| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
07-13-2010, 10:21 AM
|
#1 | |||
|
||||
|
Senior Member
|
Today in the Wall Street Journal:
http://online.wsj.com/article/SB1000...KEYWORDS=safra "Lily Safra wants to chart the course of Parkinson's disease in order to stop it. The widow of the banker Edmond J. Safra is giving $2.5 million to the New York-based Michael J. Fox Foundation to help fund a clinical study to help track the progression of Parkinson's disease. Bringing together pharmaceutical companies, nonprofits, scientists and private funders, Ms. Safra's lead gift will help form a public-private partnership to fund the five-year $40 million Parkinson's Progression Markers Initiative, which will use neuro-imaging, testing of biologic samples and behavioral assessments of 600 participants to identify so-called biomarkers of Parkinson's disease."
__________________
Carey “Cautious, careful people, always casting about to preserve their reputation and social standing, never can bring about a reform. Those who are really in earnest must be willing to be anything or nothing in the world’s estimation, and publicly and privately, in season and out, avow their sympathy with despised and persecuted ideas and their advocates, and bear the consequences.” — Susan B. Anthony |
|||
|
 Reply With Quote
|
| "Thanks for this!" says: | olsen (07-13-2010) |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| MJFF Upcoming Biomarkers Study | Parkinson's Disease | |||
| MDA's Wings Over Wall Street 07 | ALS News & Research | |||
Safra helps fund MJFF Biomarkers Study - Wall Street Journal
Linear Mode
